Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Fileti

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of the American College of Cardiology|October 19, 2010
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudyGianluca Campo, Luca Fileti, Nicoletta de Cesare, et al.
Giornale Italiano Di Cardiologia (2006)|April 27, 2023
[Twenty years of epidemiology of acute coronary syndromes in Italy: how cardiovascular epidemiology can guide secondary prevention strategies]Gian Francesco Mureddu, Paola D'Errigo, Stefano Rosato, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2020
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarctionMatteo Tebaldi, Simone Biscaglia, Andrea Erriquez, et al.
Cardiology|June 14, 2018
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT StudyMatteo Tebaldi, Simone Biscaglia, Carlo Tumscitz, et al.
Giornale Italiano Di Cardiologia (2006)|January 20, 2021
[Periprocedural management of anticoagulation therapy and in-hospital outcomes in patients with warfarin indication undergoing percutaneous coronary intervention. Data from the WAR-STENT registry]Luca Fileti, Alessandro Sciahbasi, Sabine Vecchio, et al.
American Heart Journal|August 22, 2020
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trialSimone Biscaglia, Vincenzo Guiducci, Andrea Santarelli, et al.
Heart (British Cardiac Society)|February 25, 2021
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplastyCarlo Tumscitz, Annamaria Di Cesare, Marco Balducelli, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2024
[Multidistrict atherosclerotic disease: epidemiological and clinical framework]Stefania Angela Di Fusco, Maurizio Giuseppe Abrignani, Antonio Francesco Amico, et al.
JAMA Cardiology|August 29, 2025
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction: Three-Year Outcomes of a Randomized Clinical TrialSimone Biscaglia, Andrea Erriquez, Vincenzo Guiducci, et al.
European Journal of Preventive Cardiology|March 7, 2024
Impact of pre-admission physical activity on benefits of physiology-guided complete revascularization in older patients with myocardial infarction: insights from the FIRE trialRita Pavasini, Gianluca Campo, Matteo Serenelli, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of the American College of Cardiology|October 19, 2010
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudyGianluca Campo, Luca Fileti, Nicoletta de Cesare, et al.
Giornale Italiano Di Cardiologia (2006)|April 27, 2023
[Twenty years of epidemiology of acute coronary syndromes in Italy: how cardiovascular epidemiology can guide secondary prevention strategies]Gian Francesco Mureddu, Paola D'Errigo, Stefano Rosato, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2020
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarctionMatteo Tebaldi, Simone Biscaglia, Andrea Erriquez, et al.
Cardiology|June 14, 2018
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT StudyMatteo Tebaldi, Simone Biscaglia, Carlo Tumscitz, et al.
Giornale Italiano Di Cardiologia (2006)|January 20, 2021
[Periprocedural management of anticoagulation therapy and in-hospital outcomes in patients with warfarin indication undergoing percutaneous coronary intervention. Data from the WAR-STENT registry]Luca Fileti, Alessandro Sciahbasi, Sabine Vecchio, et al.
American Heart Journal|August 22, 2020
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trialSimone Biscaglia, Vincenzo Guiducci, Andrea Santarelli, et al.
Heart (British Cardiac Society)|February 25, 2021
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplastyCarlo Tumscitz, Annamaria Di Cesare, Marco Balducelli, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2024
[Multidistrict atherosclerotic disease: epidemiological and clinical framework]Stefania Angela Di Fusco, Maurizio Giuseppe Abrignani, Antonio Francesco Amico, et al.
JAMA Cardiology|August 29, 2025
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction: Three-Year Outcomes of a Randomized Clinical TrialSimone Biscaglia, Andrea Erriquez, Vincenzo Guiducci, et al.
European Journal of Preventive Cardiology|March 7, 2024
Impact of pre-admission physical activity on benefits of physiology-guided complete revascularization in older patients with myocardial infarction: insights from the FIRE trialRita Pavasini, Gianluca Campo, Matteo Serenelli, et al.
Pageof 3